附件 107
備案費表計算
表格 S-3
(表格 類型)
十四行詩 生物治療控股公司
(註冊人在其章程中明確規定的姓名)
表 1：新登記結轉證券
| 安全類型 | 安全類標題 | 費用計算或結轉規則 | 註冊金額（2） | 建議每股最高發售價（2） | 最高總髮行價 | 收費標準 | 註冊費的數額 | |||||||||||||||||||
| 股權(1) | 普通股，每股面值0.0001美元 | — | — | — | — | — | — | |||||||||||||||||||
| 股權(1) | 優先股，每股面值0.0001美元 | — | — | — | — | — | — | |||||||||||||||||||
| 債務(1) | 債務證券 | — | — | — | — | — | — | |||||||||||||||||||
| 其他(1) | 認股權證 | — | — | — | — | — | — | |||||||||||||||||||
| 其他(1) | 單位 | — | — | — | — | — | — | |||||||||||||||||||
| 其他 | 認購權 | — | — | — | — | — | — | |||||||||||||||||||
| 未分配(通用)盤架(%1) | — | 457 | (o) | — | (3 | ) | $ | 100,000,000 | 0.00014760 | $ | 14,760.00 | |||||||||||||||
| 發售總金額 | $ | 14,760.00 | ||||||||||||||||||||||||
| 以前支付的總費用 | — | |||||||||||||||||||||||||
| 總費用抵銷 | $ | — | ||||||||||||||||||||||||
| 應繳淨費用 | $ | 14,760.00 | ||||||||||||||||||||||||
| (1) | 代表 由Sonnet BioTherapeutics Holdings，Inc.不時在一個或多個產品中提供和出售的證券。 |
| (2) | There are being registered hereunder an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, an indeterminate number of warrants to purchase common stock, preferred stock or debt securities, an indeterminate number of units, and an indeterminate number of subscription rights to purchase an indeterminate number of common stock or preferred stock, from time to time, which together shall have an aggregate initial offering price not to exceed $100,000,000. If any debt securities are issued at an original issue discount, then the offering price of such debt securities shall be in such greater principal as shall result in an aggregate offering price not to exceed $100,000,000 less the aggregate dollar amount of all securities previously issued hereunder. Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The proposed maximum offering price of the securities will be determined, from time to time, by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder. The securities registered hereunder also include an indeterminate number of shares of common stock and preferred stock and amount of debt securities as may be issued upon conversion of or exchange for preferred stock or debt securities that provide for conversion or exchange, upon exercise of warrants or subscription rights or pursuant to the anti-dilution provisions of any the securities registered hereunder. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include an indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions. |
| (3) | 每類證券的建議最高總髮行價將不時由註冊人決定 由註冊人發行本協議項下登記的證券，且未根據 一般指令II. D。根據證券法，S—3表。 |